Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NP202 in Post-MI Left Ventricular Systolic Dysfunction
NCT02557217Phase 2Unknown
- Sponsor
- Armaron Bio
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NP202 in left ventricular systolic dysfunction (LVSD), sponsored by Armaron Bio. Status: unknown.
02
Drugs
NP202
03
Conditions
left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on NCT02557217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557217.